FindTrial
Sign In

A clinical trial to detect cervical cancer at early stage with light based hand held device.

In vivo and ex vivo study for detection of cervical pre cancer with polarized fluorescence based spectral and imaging device.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009886
Enrollment
200
Registered
2017-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary health condition(s): Female patients with abnormal Pap smear findings and have probability of cervical cancer / pre-cancer.

Interventions

Intervention1: Histopathological findings: Results of the device will be compared with Histopathological findings at initial stage of trials. Intervention2: Histopathological Findings: Results of the

Sponsors

Impacting Research Innovation and Technology India
Lead Sponsor
SRISTI GYTI Award
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult and elderly female patients with sign & symptoms (such as abnormal vaginal bleeding, An unusual discharge from the vagina, pelvic pain etc.)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Co- and cross-polarized fluorescence and elastic scattering spectra. Timepoint: 15 â?? 20 minute measurement time.—

Secondary

MeasureTime frame
Different parameters to discriminate different grades of pre-cancer / cancer. Timepoint: Within 1 hr after measurements—

Countries

India

Contacts

Public ContactBharat Lal Meena

Indian Institute of Technology Kanpur

asima@iitk.ac.in5122597691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026